Committed to horses, powered by science

About us

We work together with

Management

Antonia

Antonia Gabriel

CEO/CSO

02

Katharina Birkmann

CMO

Dani Bild Website_klein

Daniel Widmer

COO

R&D Team

Fabia

Fabia Canonica

Ph.D. in Molecular Biology and Biophysics

Project Manager – Vaccine Development

Fadi

Fadi Jebbawi

Ph.D. in Immunology, Molecular and Cellular Biology

Project Manager – Biomarker

Stas

Stanislav Pantelyushin

Ph.D. in Immunology

Project Manager – Research & Preclinical Development

vicy-scaled

Victoria Fettelschoss

M.Sc. in Biochemistry, B.Sc. in Industrial Engineering and Management

Research Associate

Juwi1-web

Juwela Lam

M.Sc. ETH in Food Science and “Human Health, Nutrition and Environment”

Research Associate

Jeff-hell

Jefferson Brito de Souza

B.Sc. in Biological Science

Trainee

Clinical Team

1

Antonia Gabriel (Fettelschoss)

Dr. Sc. ETH Microbiology and Immunology

Lead clinical studies

02

Katharina Birkmann

Dr. med. vet., Dip. ECEIM

Clinical study manager

5592C498-043D-481C-BE41-D06299E5F75C_1_201_a

Sophie Hug

Dr. med. vet., Dip. ECEIM

Clinical study manager

Topicals Team

Dani

Daniel Widmer

Lead Topicals

20

Victoria Fettelschoss

Product Owner

Simon Foto

Simon Gabriel

Purchase and Distribution

saraweb

Sara Straub

Social Media

Advisors

kuendig (1)

Prof. Dr. Med. Thomas M. Kündig

  • Chair of Dermatology and Venereology at the Medical Faculty of the University of Zurich
  • Director of the Dermatological Clinic at the University Hospital Zurich
Christian Surber

Prof. Dr. phil. nat. Christian Surber

  • Professor of Dermatopharmacology and Hospital Pharmacy
  • i.a. expert in drug delivery from topical formulations, topical delivery vehicle design, topical bioavailability / bioequivalence testing, topical pharmacotherapy of barrier function impairment (dry skin, atopic dermatitis, psoriasis) and solar damage (skin cancer)

Founder

Dr. Antonia Gabriel (Fettelschoss)

  • Inventor and founder of Evax AG
  • Studied human biology at the University of Zurich and graduated with a Master of Science degree in 2008. She then started directly with a doctorate in immunology at ETH Zurich and graduated in 2011
  • During her doctorate, she worked part-time at the Clinical Trials Center Zurich and completed internships at the Swiss Institute for Allergy and Asthma (SIAF) and the Swiss Tropical Institute (TPH)
  • Certificate of Advanced Studies in Clinical Trial Management
  • After completing her doctorate, she worked as a scientist at Vifor Pharma and Saiba GmbH.
  • In addition to her work at Evax, she works as a group leader at the University of Zurich / University Hospital Zurich in the field of immunology
  • She started riding at the age of 5 and got to know Icelandic horses at the age of 12 and remains loyal to them to this day. Her family has since owned Icelandic horses, all of which were / are imports from Iceland and were / are affected by sweet itch

Prof. Martin Bachmann

  • Co-inventor and co-founder of Evax AG
  • Founder of Saiba GmbH
  • Autor von mehr als 200 wissenschaftlicher Publikationen.
  • Over 20 years of experience in the field of immunology and more than 10 years of experience in the biotech industry
  • Leading scientist in the field of active immunotherapy for chronic diseases
  • Inventor of over 40 patents in the vaccine field
  • Professor at Oxford, visiting professor at the University of Zurich and Professor of Immunology at the University of Bern

Grants

EVAX hat Mittel aus Schweizer Stipendien erhalten, darunter die Stiftung Forschung für das Pferd und die Kommission für Technologie und Innovation.